Publication | Open Access
Serum Syndecan-1: A Novel Biomarker for Pancreatic Ductal Adenocarcinoma
23
Citations
19
References
2022
Year
These findings suggest serum SDC1 as a promising novel biomarker for early blood-based diagnosis of pancreatic cancer.
| Year | Citations | |
|---|---|---|
Page 1
Page 1